Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

2 papers

Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double‐blind placebo‐controlled clinical trial

Koichiro Mori, Satoshi Inatomi, Kenzi Ouchi, Yoshihito Azumi, Takashi Tuchida
Phytotherapy Research Summary & key facts 2008 249 citations

In a small, double-blind, placebo-controlled trial of Japanese adults aged 50–80 with mild cognitive impairment, 30 people were randomly assigned to take Yamabushitake (an edible mushroom) or placebo for 16 weeks. The mushroom group took four 250 mg tablets three times a day and showed higher scores on a cognitive…

Fungal Biology and Applications Ginkgo biloba and Cashew Applications Medicinal Plants and Bioactive Compounds

Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study

Li, I-Chen, Chang, Han-Hsin, Lin, Chuan-Han, et al.
www.frontiersin.org Summary & key facts 2020 100 citations

This was a 1-year, double-blind, randomized, placebo-controlled pilot trial in people with mild Alzheimer’s disease. Participants took either three 350 mg capsules per day of Hericium erinaceus mycelia enriched with 5 mg/g erinacine A (about 5.25 mg erinacine A per day) or placebo for 49 weeks after a 3-week screening.…

Alzheimer's disease research and treatments Ginkgo biloba and Cashew Applications Phytoestrogen effects and research
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.